Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTIs your parasite protocol missing something?Adding Hill’s GI nutrition to your parasite protocol supports GI healing for more complete diarrhea management than medication alone. + Learn More